1. Home
  2. AVTX vs LEE Comparison

AVTX vs LEE Comparison

Compare AVTX & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • LEE
  • Stock Information
  • Founded
  • AVTX 2011
  • LEE 1890
  • Country
  • AVTX United States
  • LEE United States
  • Employees
  • AVTX N/A
  • LEE N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • AVTX Health Care
  • LEE Consumer Discretionary
  • Exchange
  • AVTX Nasdaq
  • LEE Nasdaq
  • Market Cap
  • AVTX 57.4M
  • LEE 52.4M
  • IPO Year
  • AVTX 2015
  • LEE N/A
  • Fundamental
  • Price
  • AVTX $4.13
  • LEE $6.20
  • Analyst Decision
  • AVTX Strong Buy
  • LEE
  • Analyst Count
  • AVTX 6
  • LEE 0
  • Target Price
  • AVTX $34.20
  • LEE N/A
  • AVG Volume (30 Days)
  • AVTX 62.6K
  • LEE 14.9K
  • Earning Date
  • AVTX 05-12-2025
  • LEE 05-08-2025
  • Dividend Yield
  • AVTX N/A
  • LEE N/A
  • EPS Growth
  • AVTX N/A
  • LEE N/A
  • EPS
  • AVTX N/A
  • LEE N/A
  • Revenue
  • AVTX $441,000.00
  • LEE $591,094,000.00
  • Revenue This Year
  • AVTX N/A
  • LEE N/A
  • Revenue Next Year
  • AVTX N/A
  • LEE N/A
  • P/E Ratio
  • AVTX $0.59
  • LEE N/A
  • Revenue Growth
  • AVTX N/A
  • LEE N/A
  • 52 Week Low
  • AVTX $3.39
  • LEE $6.15
  • 52 Week High
  • AVTX $16.00
  • LEE $19.63
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 45.63
  • LEE 24.76
  • Support Level
  • AVTX $3.43
  • LEE $6.15
  • Resistance Level
  • AVTX $4.03
  • LEE $6.97
  • Average True Range (ATR)
  • AVTX 0.34
  • LEE 0.28
  • MACD
  • AVTX 0.09
  • LEE -0.06
  • Stochastic Oscillator
  • AVTX 70.47
  • LEE 1.48

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: